Cargando…
Inflammatory Markers and Poor Outcome after Stroke: A Prospective Cohort Study and Systematic Review of Interleukin-6
BACKGROUND: The objective of this study was to determine whether: (a) markers of acute inflammation (white cell count, glucose, interleukin-6, C-reactive protein, and fibrinogen) are associated with poor outcome after stroke and (b) the addition of markers to previously validated prognostic models i...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730573/ https://www.ncbi.nlm.nih.gov/pubmed/19901973 http://dx.doi.org/10.1371/journal.pmed.1000145 |
_version_ | 1782170906263552000 |
---|---|
author | Whiteley, William Jackson, Caroline Lewis, Steff Lowe, Gordon Rumley, Ann Sandercock, Peter Wardlaw, Joanna Dennis, Martin Sudlow, Cathie |
author_facet | Whiteley, William Jackson, Caroline Lewis, Steff Lowe, Gordon Rumley, Ann Sandercock, Peter Wardlaw, Joanna Dennis, Martin Sudlow, Cathie |
author_sort | Whiteley, William |
collection | PubMed |
description | BACKGROUND: The objective of this study was to determine whether: (a) markers of acute inflammation (white cell count, glucose, interleukin-6, C-reactive protein, and fibrinogen) are associated with poor outcome after stroke and (b) the addition of markers to previously validated prognostic models improves prediction of poor outcome. METHODS AND FINDINGS: We prospectively recruited patients between 2002 and 2005. Clinicians assessed patients and drew blood for inflammatory markers. Patients were followed up by postal questionnaire for poor outcome (a score of>2 on the modified Rankin Scale) and death through the General Register Office (Scotland) at 6 mo. We performed a systematic review of the literature and meta-analysis of the association between interleukin-6 and poor outcome after stroke to place our study in the context of previous research. We recruited 844 patients; mortality data were available in 844 (100%) and functional outcome in 750 (89%). After appropriate adjustment, the odds ratios for the association of markers and poor outcome (comparing the upper and the lower third) were interleukin-6, 3.1 (95% CI: 1.9–5.0); C-reactive protein, 1.9 (95% CI: 1.2–3.1); fibrinogen, 1.5 (95% CI: 1.0–2.36); white cell count, 2.1 (95% CI: 1.3–3.4); and glucose 1.3 (95% CI: 0.8–2.1). The results for interleukin-6 were similar to other studies. However, the addition of inflammatory marker levels to validated prognostic models did not materially improve model discrimination, calibration, or reclassification for prediction of poor outcome after stroke. CONCLUSIONS: Raised levels of markers of the acute inflammatory response after stroke are associated with poor outcomes. However, the addition of these markers to a previously validated stroke prognostic model did not improve the prediction of poor outcome. Whether inflammatory markers are useful in prediction of recurrent stroke or other vascular events is a separate question, which requires further study. Please see later in the article for the Editors' Summary |
format | Text |
id | pubmed-2730573 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-27305732009-09-08 Inflammatory Markers and Poor Outcome after Stroke: A Prospective Cohort Study and Systematic Review of Interleukin-6 Whiteley, William Jackson, Caroline Lewis, Steff Lowe, Gordon Rumley, Ann Sandercock, Peter Wardlaw, Joanna Dennis, Martin Sudlow, Cathie PLoS Med Research Article BACKGROUND: The objective of this study was to determine whether: (a) markers of acute inflammation (white cell count, glucose, interleukin-6, C-reactive protein, and fibrinogen) are associated with poor outcome after stroke and (b) the addition of markers to previously validated prognostic models improves prediction of poor outcome. METHODS AND FINDINGS: We prospectively recruited patients between 2002 and 2005. Clinicians assessed patients and drew blood for inflammatory markers. Patients were followed up by postal questionnaire for poor outcome (a score of>2 on the modified Rankin Scale) and death through the General Register Office (Scotland) at 6 mo. We performed a systematic review of the literature and meta-analysis of the association between interleukin-6 and poor outcome after stroke to place our study in the context of previous research. We recruited 844 patients; mortality data were available in 844 (100%) and functional outcome in 750 (89%). After appropriate adjustment, the odds ratios for the association of markers and poor outcome (comparing the upper and the lower third) were interleukin-6, 3.1 (95% CI: 1.9–5.0); C-reactive protein, 1.9 (95% CI: 1.2–3.1); fibrinogen, 1.5 (95% CI: 1.0–2.36); white cell count, 2.1 (95% CI: 1.3–3.4); and glucose 1.3 (95% CI: 0.8–2.1). The results for interleukin-6 were similar to other studies. However, the addition of inflammatory marker levels to validated prognostic models did not materially improve model discrimination, calibration, or reclassification for prediction of poor outcome after stroke. CONCLUSIONS: Raised levels of markers of the acute inflammatory response after stroke are associated with poor outcomes. However, the addition of these markers to a previously validated stroke prognostic model did not improve the prediction of poor outcome. Whether inflammatory markers are useful in prediction of recurrent stroke or other vascular events is a separate question, which requires further study. Please see later in the article for the Editors' Summary Public Library of Science 2009-09-08 /pmc/articles/PMC2730573/ /pubmed/19901973 http://dx.doi.org/10.1371/journal.pmed.1000145 Text en Whiteley et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Whiteley, William Jackson, Caroline Lewis, Steff Lowe, Gordon Rumley, Ann Sandercock, Peter Wardlaw, Joanna Dennis, Martin Sudlow, Cathie Inflammatory Markers and Poor Outcome after Stroke: A Prospective Cohort Study and Systematic Review of Interleukin-6 |
title | Inflammatory Markers and Poor Outcome after Stroke: A Prospective Cohort Study and Systematic Review of Interleukin-6 |
title_full | Inflammatory Markers and Poor Outcome after Stroke: A Prospective Cohort Study and Systematic Review of Interleukin-6 |
title_fullStr | Inflammatory Markers and Poor Outcome after Stroke: A Prospective Cohort Study and Systematic Review of Interleukin-6 |
title_full_unstemmed | Inflammatory Markers and Poor Outcome after Stroke: A Prospective Cohort Study and Systematic Review of Interleukin-6 |
title_short | Inflammatory Markers and Poor Outcome after Stroke: A Prospective Cohort Study and Systematic Review of Interleukin-6 |
title_sort | inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730573/ https://www.ncbi.nlm.nih.gov/pubmed/19901973 http://dx.doi.org/10.1371/journal.pmed.1000145 |
work_keys_str_mv | AT whiteleywilliam inflammatorymarkersandpooroutcomeafterstrokeaprospectivecohortstudyandsystematicreviewofinterleukin6 AT jacksoncaroline inflammatorymarkersandpooroutcomeafterstrokeaprospectivecohortstudyandsystematicreviewofinterleukin6 AT lewissteff inflammatorymarkersandpooroutcomeafterstrokeaprospectivecohortstudyandsystematicreviewofinterleukin6 AT lowegordon inflammatorymarkersandpooroutcomeafterstrokeaprospectivecohortstudyandsystematicreviewofinterleukin6 AT rumleyann inflammatorymarkersandpooroutcomeafterstrokeaprospectivecohortstudyandsystematicreviewofinterleukin6 AT sandercockpeter inflammatorymarkersandpooroutcomeafterstrokeaprospectivecohortstudyandsystematicreviewofinterleukin6 AT wardlawjoanna inflammatorymarkersandpooroutcomeafterstrokeaprospectivecohortstudyandsystematicreviewofinterleukin6 AT dennismartin inflammatorymarkersandpooroutcomeafterstrokeaprospectivecohortstudyandsystematicreviewofinterleukin6 AT sudlowcathie inflammatorymarkersandpooroutcomeafterstrokeaprospectivecohortstudyandsystematicreviewofinterleukin6 |